Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice

Diabetologia

Volumn 48, Issue 10, 2005, Pages 2140-2146

  Ahren B ^a   Thomaseth, K ^b   Pacini, G ^b  

^a LUND UNIVERSITY   (Sweden)

^b CNR   (Italy)

Author keywords

C peptide kinetics; GLP 1; Glucagon like peptide 1; Insulin clearance; Insulin secretion; IVGTT; Mathematical modelling; Population modelling

Indexed keywords

C PEPTIDE; GLUCAGON LIKE PEPTIDE 1;

ARTICLE; COMPARTMENT MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; KINETICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REDUCTION;

ANIMALS; AREA UNDER CURVE; C-PEPTIDE; FEMALE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; INJECTIONS, INTRAVENOUS; INSULIN; INSULIN-SECRETING CELLS; KINETICS; MICE;

EID: 26244438849     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1915-z     Document Type: Article

References (21)

1. Polonsky KS, Rubenstein H (1984) C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 33:486-494
2. Rabkin R, Ryan MP, Duckworth WC (1984) The renal metabolism of insulin. Diabetologia 27:351-357
3. Sonksen PH, Tompkins CV, Srivastava MC, Nabarro JD (1973) A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med 45:633-654
4. Creutzfeldt W, Ebert R (1985) New developments in the incretin concept. Diabetologia 28:565-573
5. Madsbad S, Kehlet H, Hilsted J, Tronier B (1983) Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose. Diabetes 32:436-438
6. Hampton SM, Morgan LM, Tredger JA, Cramb R, Marks V (1986) Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion. Diabetes 35:612-616
7. Shuster LT, Go VLW, Rizza RA, O'Brien PC, Service FJ (1988) Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes 37:200-203
8. Ikeda T, Yoshida T, Honda M et al (1987) Effect of intestinal factors on extraction of insulin in perfused rat livers. Am J Physiol 253:E603-E607
9. Holst JJ, Gromada J (2004) Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol 287:E199-E206
10. Deacon CF (2004) Therapeutic strategies based on glucagon-like peptide-1. Diabetes 53:2181-2189
11. Ahrén B, Schmitz O (2004) GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes. Horm Metab Res 36:867-876
12. Filipsson K, Holst JJ, Ahrén B (2000) PACAP contributes to insulin secretion after gastric glucose gavage in mice. Am J Physiol 279:R424-R432
13. Ahrén B, Pacini G (1999) Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice. Am J Physiol 277:E996-E1004
14. Pacini G, Thomaseth K, Ahrén B (2001) Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol 281:E693-E703
15. Seber GAF, Wild CS (1989) Nonlinear regression. Wiley, New York
16. Davidian M, Giltinan DM (1995) Nonlinear models for repeated measurement data. Chapman Hall, London
17. Pinheiro JC, Bates DM (2000) Mixed-effects models in S and S-PLUS. Springer, Berlin Heidelberg New York
18. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparisons of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
19. Thomaseth K, Kautzky-Willer A, Ludvik B, Prager R, Pacini G (1996) Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am J Physiol 270:E522-E531
20. Polonsky KS, Linicio-Paixao J, Given BD et al (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J Clin Invest 77:98-105
21. Watanabe RM, Bergman RN (2000) Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics. Diabetes 49:332-373